The identification of EWSR1 gene fusions is crucial for the diagnosis and treatment of specific cancers. These fusions serve as diagnostic markers that can help distinguish between different types of tumors. Moreover, understanding the molecular mechanisms of EWSR1 fusions opens up opportunities for targeted therapies. For instance, drugs that inhibit the activity of fusion proteins or disrupt their formation are being actively researched.